Berberine and your medications: what interacts, and what to avoid entirely.

It has a real, drug-like effect on blood sugar. That is the reason to take it seriously, and the reason it belongs on the list you hand your GP.

Berberine has spent two years being sold as nature's Ozempic. It is not that, and the comparison manages to flatter and insult it at the same time. What berberine actually is, on the evidence, is a supplement with a genuine, medicine-like effect on blood sugar. That is the reason to take it seriously. It is also the reason it collides with prescriptions unusually often for a supplement, and why the question people usually ask about it, whether berberine is safe, has no useful answer on its own. Safe alongside what?

Does berberine interact with medications?

Yes, and nearly all of it comes back to two mechanisms.

The first is the one it is sold for. Berberine lowers blood glucose in its own right, and a meta-analysis of 37 randomised trials found, across the 31 of them that measured it, that berberine lowered HbA1c, the three-month average of your blood sugar, by 0.63 percentage points (PMID 36467075). So combining it with a medicine that also lowers glucose can take you lower than either was aimed at, which calls for close glucose monitoring in the first few weeks. The trials in that review most often used between 0.9 and 2.4 grams a day (PMID 36467075). Berberine is conventionally split across meals, and a typical shelf product sits at the lower end of that range.

The second is the one almost nobody mentions. Berberine slows two of the body's clearance routes: CYP3A4, a liver enzyme, and P-glycoprotein, a pump in the gut wall that pushes drugs back out before they are fully absorbed. The enzyme half has been measured directly in people: two weeks of berberine raised exposure to a test drug cleared by CYP3A4 by about 40% in a randomised crossover trial in healthy men (PMID 21870106). Between them those two routes handle a long list of prescriptions, so slowing them tends to leave more of a drug in the blood than the dose intended. For most medicines that is a monitoring question, but for a few, where the gap between the working dose and the harmful one is narrow, it is not.

We have assessed every berberine-and-medicine pair in the database. Seventeen carry a finding: four red, thirteen amber, none green. Most of the rest came back clear.

That ratio is unusual, and it is not evidence that berberine is uniquely dangerous. It is what you would expect from a compound with a real pharmacological effect. Most of what we assess earns a green because it does not do enough to collide with a prescription in the first place.

Can you take berberine with metformin?

Berberine and metformin lower blood glucose through overlapping pathways, so taking them together adds one effect to the other and can push your glucose too low, which makes this a monitor-and-tell-your-GP combination rather than a flat no. The overlap is not a coincidence. A placebo-controlled trial in 116 people with type 2 diabetes and raised blood lipids found berberine lowered fasting glucose, post-meal glucose, HbA1c and LDL cholesterol against placebo over three months (PMID 18397984), and it does that partly through AMPK, the same energy-sensing pathway metformin works on.

How careful you need to be depends on which diabetes medicine you take, and the map is more useful here than a single warning. The steepest combinations are with the drugs that can cause low blood sugar on their own: gliclazide, glimepiride and the other sulfonylureas, and insulin. Berberine adds to a risk those already carry, so if you take one of them, check your glucose closely when you start berberine and expect your prescriber to want to review the dose.

The lower-risk combinations are with sitagliptin and the other gliptins, dapagliflozin and the SGLT2 drugs, and pioglitazone, though lower-risk is not no-risk: these lower glucose in ways that rarely tip into hypoglycaemia by themselves, so the combination tends to be well tolerated, and checking your glucose at the start and telling your GP you have added berberine is still the sensible step.

One honest qualification, because it cuts against the warning above. That same review looked for hypoglycaemia across nine of its trials, 820 people in total, covering berberine on its own and berberine added to standard diabetes tablets. In seven of those nine, nobody in either group had a single episode. So the comparison rests on the two trials that recorded any, 186 people between them, and across those berberine showed no significant rise (PMID 36467075). The caution above is about where the risk concentrates, in the first weeks and with the drugs that can drop your sugar on their own, and it is not a claim that low blood sugar is the usual outcome.

One rule holds across all of them: do not change your own dose. If berberine is working, your prescription may need reducing, and that is a decision for whoever manages your diabetes, made on your glucose readings.

Which medications should you never take with berberine?

Transplant immunosuppressants. Berberine slows both of the routes the body uses to clear ciclosporin, tacrolimus, sirolimus and everolimus, so it can push those drug levels toward the range where they cause harm instead of protecting the graft, and this is the one place on the list where the answer is do not combine outside your transplant team's direct supervision.

The evidence here is stronger than most supplement warnings and thinner than it first looks, and both halves deserve saying. A randomised controlled trial in 104 kidney-transplant recipients gave berberine to half of them alongside ciclosporin for three months, and their ciclosporin trough levels finished about 29% higher than the group who took ciclosporin alone; a smaller pharmacokinetic arm measured total exposure up by about 35% (PMID 16133554). That is a trial in patients, with numbers attached, and it is the strongest interaction evidence berberine has.

It is also the only one of the four that has been directly tested: tacrolimus, sirolimus and everolimus are graded red by inference, because they travel through the same enzyme and the same pump, and all four are drugs whose blood levels are monitored precisely because the margin between too little and too much is thin. We could wait for three more trials. Given what is at stake for a transplant if the inference is right, we would rather grade them red now and tell you openly that three of the four are extrapolated from the mechanism.

The same reasoning puts antiretroviral therapy for HIV in the same bracket, since much of it is cleared by CYP3A4 too, and our report engine excludes berberine outright for anyone on it.

What about statins, blood pressure tablets and digoxin?

Three people rarely think to check. None is an emergency.

Statins. Berberine lowers LDL cholesterol by about 25% on its own in the trial that identified it as a cholesterol-lowering drug, by a route those researchers called distinct from a statin's (PMID 15531889): it increases the number of receptors that pull cholesterol out of the blood, where a statin slows the making of it. Taken together the two effects add up, which is sometimes what you want and sometimes takes your lipids lower than your GP was aiming for, so ask for a lipid panel sooner than your usual check, and do not stop either on your own. We grade this pair amber on limited evidence, which means small trials, not an absence of them.

Blood pressure tablets. Berberine appears to lower blood pressure modestly, and a meta-analysis found that adding it to a blood pressure medicine tended to lower pressure further than that medicine achieved alone, though blood pressure was one of three conditions that review covered, only four of its twenty-seven trials looked at it, and the add-on comparison used two of those four (PMID 25498346). Alongside amlodipine, ramipril, losartan or their relatives, that can occasionally leave you light-headed or running lower than intended, so check your blood pressure in the first few weeks and tell your GP you have started. The effect is small and the underlying trials are not strong, which is why berberine alongside a blood pressure medicine is a monitoring note and not a warning, though it is still worth raising with your GP.

Digoxin. Digoxin is a drug where a small shift in blood level matters, and berberine's effect on the gut pump that limits how much of it gets absorbed may raise that level, so if you take both it is worth knowing the signs of too much digoxin, which are nausea, disturbed vision and an irregular pulse, and worth asking your GP whether a level check is warranted. The evidence behind that one deserves saying plainly, because it is thinner than the others. The digoxin measurements were made in rats, where berberine raised the absorption of swallowed digoxin by 23 to 70% and left injected digoxin untouched, which is what pump inhibition in the gut wall looks like (PMID 19370549). No equivalent measurement has been made in people. Because the human evidence is indirect, we grade berberine and digoxin amber rather than red, and still worth raising with your GP.

Is berberine safe with everything else?

Mostly yes, and the word mostly is doing real work: the pairs that carry a finding are the ones set out above, and we can say the rest with more confidence for berberine than for most compounds because it is one we have taken all the way through. It has been assessed against all 296 medications in our database, the obscure ones included. Most of the pairs that produced nothing show green on our checker because somebody looked and found nothing, rather than because nobody looked. One exception is worth stating plainly: if you take antiretroviral therapy for HIV, treat berberine as off the table whatever any checker shows you, ours included, and raise it with your HIV team.

That distinction matters more than it looks. "No known interaction" and "nobody has checked" read identically on almost every website, and they are not the same sentence. If your prescription is not on the list above, the useful thing is not our reassurance in an essay; it is checking the specific pair.

One last thing, which is not an interaction but belongs in an honest piece about berberine. You may see it sold for longevity, on the grounds that it activates AMPK, an energy-sensing pathway that comes up often in ageing research. We removed longevity from berberine's entry in our own database, because a pathway is a mechanism and not a result, and not one of the studies we cite measures ageing, healthspan or how long anybody lived. The blood-sugar evidence is good. The ageing claim is borrowed from a diagram.

If you want to check berberine against your own prescriptions, our free interactions checker gives you the graded answer with the study behind it, and the berberine page lists every pair we have assessed, each one cited. Neither costs anything. We do not sell supplements and we earn no commission on anything you buy, so we have no stake in which way the answer comes out.

Berberine behaves like a medicine, which is the reason it works and the reason it collides. Tell your GP you are taking it.